Beijing Konruns Pharmaceutical Co.,Ltd.

¥25.65As of Sun 8 Nov 2026, 12:00 UTC
SSE:603590Healthcare
Country China
PE (Fwd) •••
TSR 8Y CAGR (7.04%)
Div yield 1.36%
ROE 4.00%
Biotechnology
Beta (5Y) 0.51
PE TTM 29.76
TSR TTM (48.65%)
Mkt cap ¥4.027B
ROIC 4.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥33
27.08%
(50.70%)
Buy 11|1|5|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.44
0.44
0.46
0.46
13.17%
3.42%
9.59%
5.20%
Revenue¥M
304.8
319.5
328.6
324.7
8.65%
15.27%
18.12%
11.70%
Peers (US$603.7M)
Cap (US$)
PE
604.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.183
0.063
0.051
EBIT/Intx
3.640
0.115
0.120
Own earn%
22.10
(175.99)
(180.33)
Sh yield%
28.93
48.21
49.19
Owners
Insiders/Inst%
10.55
55.04
Short interest%
3.14
SBC / revenue%
1.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
17